Knockdown of CYP1A1 has been shown to impair proliferation and survival in the breast cancer cell lines MCF-7 and MDA-MB-231 through activation of AMPK signaling and inhibition of the phosphorylation of AKT, ERK and P70S6K [22]. Here, CYP1A1 is linked to breast carcinoma.